D
DMAC
Diamedica Therapeutics Inc
8.42
-0.08-0.94%After Hours: 8.55 +0.13 +1.54%17:47 02/20 EST
OPEN/PREV CLOSE8.39/8.50
TODAY RANGE8.10-8.49
VOL180.63K
MARKET CAP451.13M
52 WEEK RANGE3.190-10.42
AVG VOL (3M)326.04K
% TURNOVER0.34%
TURNOVER--
P/E (TTM)-11.7368
% RANGE4.35%
EPS(TTM)-0.7174
P/E(FORWARD)-11.7762
P/B8.49
BVPS0.9913
DIVIDEND--
P/S25.70
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP256.12M
SHARES OUTSTANDING53.58M
NEXT EARNINGS03/16-03/20
FREE FLOAT30.42M
LOT SIZE1
EX-DATE11/15/2018
News
Press Releases
Financial Reports
Profile
TipRanks·01/22 12:46
Cantor Fitzgerald Sticks to Its Buy Rating for Diamedica Therapeutics (DMAC)
TipRanks·01/05 14:49
DiaMedica Therapeutics Raises Capital via Share Offering
TipRanks·01/05 13:46
DiaMedica Therapeutics named a Top Idea for 2026 at Lake Street
TipRanks·12/20/2025 05:45
Craig-Hallum Reaffirms Their Buy Rating on Diamedica Therapeutics (DMAC)
NASDAQ·12/19/2025 04:27
After-Hours Biotech Rally: Inspira, MediciNova, DiaMedica Therapeutics Among Gainers
TipRanks·12/18/2025 14:16
DiaMedica Therapeutics provides DM199 update following FDA meeting
TipRanks·12/18/2025 14:14
DiaMedica Advances DM199 Preeclampsia Program After FDA Pre-IND Meeting
Reuters·12/18/2025 13:45
DiaMedica Therapeutics Advances DM199 Preeclampsia Clinical Program Following FDA Meeting
Reuters·12/18/2025 13:45
DIAMEDICA THERAPEUTICS INC - STUDY RESULTS EXPECTED BY Q2 2026
TipRanks·12/09/2025 02:03
Major Investment Alert: Diamedica Therapeutics Sees Significant Shareholder Action!
Same Industry
Name/Symbol
Change%
Price